We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Plant Extract Effective Against Psoriasis

By Biotechdaily staff writers
Posted on 09 Jun 2006
A team of research dermatologists reported success in treating psoriasis with a salve containing an extract of the barberry plant, Mahonia aquifolium.

Psoriasis is a difficult disorder to treat because the severity and distribution of psoriatic plaques vary greatly, and because current medications can have undesirable side effects. More...
Investigators at the Dermatology and Cosmetic Center (Rochester, NY, USA) treated a group of 200 patients suffering from mild to moderate psoriasis with a salve containing M aquifolium extract. A control group of 97 individuals was treated with a placebo. After 12 weeks, these 97 controls and 74 patients who had finished the complete course of twice-a-day treatments were evaluated, using Psoriasis Area Severity Index (PASI) and Quality of Life Index (QLI) questionnaires.

Results published in the April 2006 issue of the American Journal of Therapeutics indicated statistically significant improvements in PASI and QLI in the Mahonia-treated group, compared with the control group. Side effects reported were infrequent, and minor; the most frequent side effects were rash, a burning sensation when applying the cream, and clothing stain.

The investigators concluded that, "The cream containing M aquifolium extract was a safe and effective treatment for mild to moderate psoriasis.”



Related Links:
Dermatology and Cosmetic Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Automated Urinalysis Solution
UN-9000
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.